Good News -- I just called Aderans Research Institute in Atlanta
Collapse
X
-
However, Aderans being released was going through FDA approvals and not the approvals of any asian health ministries. Only way that Aderans Phase II could be approved in an asian country was if that countries health ministry recognized FDA trials and approvals without any hoops to jump through.Comment
-
AFAIK its not a myth as Replicel is targeting a 2015 release after Phase II and Histogen is targeting a 2015-16 release after Phase IIb, both in Asia.
However, Aderans being released was going through FDA approvals and not the approvals of any asian health ministries. Only way that Aderans Phase II could be approved in an asian country was if that countries health ministry recognized FDA trials and approvals without any hoops to jump through.Comment
-
Comment
-
It needs to be said though, that if Aderan's didn't see this coming given their abysmal turnaround time, they failed miserably at having a backup plan for funding from another entity.
As an investor, waiting 10+ years with another clinical trial remaining and the most costly would piss me off. But if that meant at the expense of wigs and surgical procedures which their stem cell treatment could provide, hell no would those businessmen assholes ever allow that. They don't give a shit about balding men, they have ZERO empathy for anyone, they care about one thing only; DOLLARS.Comment
-
Actually that's exactly why I think they failed. Perhaps it actuàlly costs them too much to make it. It didn't turn out to be consumable...Comment
-
Comment
-
Hmmm....on this note, keep in mind that Cosmo's Methylene Blue product is garnering interest from big pharma and seems to be their primary "star" drug. (But I could be wrong).
If Big Pharma buys Cosmo with view to getting access to the MB product, given they've shown no interest in MPB, it wouldn't surprise me if they killed CB in the pipeline.
God, I'm such an asshole.Comment
-
Hmmm....on this note, keep in mind that Cosmo's Methylene Blue product is garnering interest from big pharma and seems to be their primary "star" drug. (But I could be wrong).
If Big Pharma buys Cosmo with view to getting access to the MB product, given they've shown no interest in MPB, it wouldn't surprise me if they killed CB in the pipeline.
God, I'm such an asshole.Comment
-
then what are you doing here? just being a troll? if you know none of these products are ever going to be released then why don't you get off here and get on with your life instead of sitting on here trying to make everyone feel sad and pathetic like you?Comment
-
Guaranteed how exactly?Comment
-
Man this is really ****ed up, Shiesedo just invested a massive amount into Replicel, I dont see why the same cant happen with Aderans??? They're even closer to market than Replicel!
It just looks like no progress has been made and we're back to 2007.Comment
-
I will be immensely surprised if a company doesnt buy out Aderans.
I mean if Shisedo can spend millions on Replicel and they have only just finished Phase I, then I'm sure a company will be willing to buy Aderans who is heading into Phase III with two successful trials backing them and a working protocol.
Why on earth does MILLIONS get spend on worthless make-up products for women and when the cure for baldness is in question nobody seems to give a ****.Comment
Comment